Article
Fujisawa Inc, released data recently that supports the safety and efficacy of Protopic (tacrolimus ointment) 0.03 percent concentration in children with mild to moderate atopic dermatitis.
The Future of Pediatric Care at MOPD
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Pediatric Patients with Atopic Dermatitis Have Lower SCH and Higher TEWL, Compared to Those Without
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Pediatric Melanoma in Review: Providing Considerations for Dermatologists
Shanna Miranti, MPAS, PA-C, Shares Expert Acne and Pediatric Dermatology Insights